This document studies the effects of sporamin, a protein from sweet potatoes, on human gut cancer cell lines. It finds that sporamin exerts significant anti-proliferative and anti-metastatic effects by inducing apoptosis in human pancreatic, esophageal, and colorectal cancer cell lines. Specifically, sporamin treatment was found to suppress tumor growth through influencing expression of Bcl-2 family proteins and inhibiting the NF-κB pathway. Figures 1-3 show results of experiments demonstrating sporamin's dose-dependent inhibition of cancer cell proliferation and induction of apoptosis.